Navient's sale of its Healthcare Services business to CorroHealth for $365 million cash is a significant move in its strategic simplification plan. With a book value of $136 million as of June 30, this transaction likely results in a substantial gain, potentially over $200 million. This influx of cash could strengthen Navient's balance sheet and provide flexibility for debt reduction or shareholder returns. The divestiture of non-core assets aligns with industry trends of focusing on core competencies. However, investors should note that this sale reduces Navient's revenue diversification. The potential sale of the Government Services business, with a $192 million book value, could further impact the company's financial structure and future earnings potential. Overall, this move signals a shift towards a leaner, more focused operation, which could lead to improved operational efficiency and potentially higher profit margins in the long term.